The CD61+ progenitor cell is the cell of origin for basal breast cancers [15],[16] and Elf5 is expressed predominantly by the ER− progenitor subset [17], suggesting, together with the developmental effects of Elf5 outlined above, a role for ELF5 in determining aspects of molecular subtype of breast cancer. Here, ITGB3 is linked to breast carcinoma.